Candid Therapeutics
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic Diseases (NCT07712939) | Candid Therapeutics | 2026-07-20 |
| A Clinical Study of Cizutamig in Thyroid Eye Disease (NCT07597200) | Candid Therapeutics | 2026-05-08 |
| A Phase 1 Study of Cizutamig in IgE Mediated Diseases (NCT07408869) | Candid Therapeutics | 2026-04-01 |
| Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG) (NCT07215650) | Candid Therapeutics | 2025-09-16 |
| Clinical Study of Cizutamig in Systemic Lupus Erythematosus (NCT07215663) | Candid Therapeutics | 2025-09-04 |
| An Open-label Study of CND261 in Seropositive Rheumatoid Arthritis (NCT07052032) | Candid Therapeutics | 2025-06-16 |
Track Candid Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.